4//SEC Filing
GENELABS TECHNOLOGIES INC /CA 4
Accession 0001236259-05-000004
CIK 0000874443operating
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 5:19 PM ET
Size
8.2 KB
Accession
0001236259-05-000004
Insider Transaction Report
Form 4
AHMED MUMTAZ
V.P.Drug Development
Transactions
- Award
Option Grant
2005-01-27$0.88/sh+40,000$35,200→ 60,000 totalExercise: $0.88Exp: 2015-01-27→ common stock (40,000 underlying) - Award
Option Grant
2005-01-27$0.88/sh+20,000$17,600→ 20,000 totalExercise: $0.88Exp: 2015-01-27→ common stock (20,000 underlying)
Footnotes (2)
- [F1]These options become 50% exercisable on June 30, 2005 and the remainder pro rata monthly over the next six months.
- [F2]These options become 25% exercisable one year from grant date and the remainder pro rata monthly over the next three years.
Documents
Issuer
GENELABS TECHNOLOGIES INC /CA
CIK 0000874443
Entity typeoperating
IncorporatedCA
Related Parties
1- filerCIK 0000874443
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 5:19 PM ET
- Size
- 8.2 KB